Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-18-058797

President and CEO sold 18,334 shares at an average $18.09 ($331,664)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Watts Ryan J. President and CEO 2018-11-13 Sale −4,746 $18.00 $85,428 2,742,892 I
Watts Ryan J. President and CEO 2018-11-15 Sale −13,588 $18.12 $246,236 2,729,304 I
Open-market sales · 18,334 sh · avg $18.09 · $331,664
Loading xslF345X03/doc4.xml…